Autonomix Medical, Inc.
AMIX
$0.44
-$0.02-4.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 48.40% | 38.85% | 3.74% | 28.79% | 81.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 63.23% | 55.13% | 30.98% | 55.02% | 88.10% |
| Operating Income | -63.23% | -55.13% | -30.98% | -55.02% | -88.10% |
| Income Before Tax | -26.52% | -18.99% | 30.20% | 26.04% | -27.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.52% | -18.99% | 30.20% | 26.04% | -27.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.52% | -18.99% | 30.20% | 26.04% | -27.64% |
| EBIT | -63.23% | -55.13% | -30.98% | -55.02% | -88.10% |
| EBITDA | -65.48% | -56.30% | -51.56% | -115.91% | -262.98% |
| EPS Basic | 62.46% | 58.38% | 68.06% | 60.20% | 25.84% |
| Normalized Basic EPS | 62.46% | 58.38% | 68.06% | 60.20% | 25.84% |
| EPS Diluted | 62.46% | 58.38% | 68.06% | 60.20% | 25.84% |
| Normalized Diluted EPS | 62.46% | 58.38% | 68.06% | 60.20% | 25.84% |
| Average Basic Shares Outstanding | 269.40% | 182.95% | 118.63% | 101.28% | 85.54% |
| Average Diluted Shares Outstanding | 269.40% | 182.95% | 118.63% | 101.28% | 85.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |